Dissection of transcriptomic and epigenetic heterogeneity of grade 4 gliomas: implications for prognosis.
Chang ZengXiao SongSheng ZhangQinyun CaiJiajun CaiCraig HorbinskiBo HuShi-Yuan ChengWei ZhangPublished in: Acta neuropathologica communications (2023)
The 5hmC-based prognostic model could offer a robust tool to predict survival in patients with grade 4 gliomas, potentially outperforming existing prognostic factors such as IDH1 mutations. The crosstalk between 5hmC and gene expression revealed another layer of complexity underlying the molecular heterogeneity in grade 4 gliomas, offering opportunities for identifying novel therapeutic targets.